Neuroprotection for Parkinson's disease using viral vector-mediated delivery of GDNF

Prog Brain Res. 2002:138:421-32. doi: 10.1016/S0079-6123(02)38091-9.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Brain / metabolism
  • Brain / pathology
  • Brain / virology
  • Genetic Therapy / methods
  • Genetic Therapy / trends*
  • Genetic Vectors / therapeutic use*
  • Glial Cell Line-Derived Neurotrophic Factor
  • Humans
  • Models, Animal
  • Nerve Growth Factors / genetics*
  • Nerve Growth Factors / therapeutic use*
  • Neuroprotective Agents / therapeutic use*
  • Parkinson Disease / therapy*
  • Treatment Outcome
  • Viruses / genetics*

Substances

  • GDNF protein, human
  • Glial Cell Line-Derived Neurotrophic Factor
  • Nerve Growth Factors
  • Neuroprotective Agents